Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 17/20 | 1.00 |
| ▸ | CRBN | Q96SW2 | 17/20 | 1.00 |
| ▸ | IKZF3 | Q9UKT9 | 2/20 | 0.68 |
| ▸ | TNF | P01375 | 1/20 | 0.68 |
| ▸ | IL1B | P01584 | 1/20 | 0.68 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.68 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.65 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15930069 | 1.00 | DDB1 (1.00) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL2110965 | 1.00 | DDB1 (1.00) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL1398974 | 1.00 | DDB1 (1.00) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL1096288 | 1.00 | DDB1 (1.00) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL15930063 | 1.00 | DDB1 (1.00) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL19611941 | 0.93 | DDB1 (0.87) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL18263911 | 0.93 | DDB1 (0.87) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL18263926 | 0.93 | DDB1 (0.87) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL19359185 | 0.90 | DDB1 (0.82) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL29923364 | 0.90 | DDB1 (0.82) | DDB1CRBNIKZF3TNFIL1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115557936-B | Preparation method and application of pomalidomide derivative serving as feed additive | 河南湾流生物科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-109678840-B | Preparation method of pomalidomide | 河北菲尼斯生物技术有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-115572283-A | Pomalidomide feed additive and preparation method and application thereof | 河南湾流生物科技有限公司 | 2023-01-06 | — | — | CN | claimed |
| CN-115557936-A | Preparation method and application of pomalidomide derivative capable of being used as feed additive | 河南湾流生物科技有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-114605381-A | Preparation method of pomalidomide | 南京海辰药业股份有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-121574723-A | Application of pomalidomide and various derivatives thereof as electrochemiluminescence probes | 厦门医学院 | 2026-02-27 | — | — | CN | disclosed |
| WO-2024256569-A1 | NOVEL CDK DEGRADERS | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2024-12-19 | — | — | WO | disclosed |
| CN-115572283-B | Pomalidomide feed additive and preparation method and application thereof | 合肥市贵谦信息科技有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-115572283-B | Pomalidomide feed additive and preparation method and application thereof | 合肥市贵谦信息科技有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-115557936-B | Preparation method and application of pomalidomide derivative serving as feed additive | 河南湾流生物科技有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-112771038-B | Pyridazine derivatives as SMARCA2/4 degrading agents | 奥里吉恩发现科技有限公司 | 2024-09-24 | — | — | CN | disclosed |
| WO-2024178067-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-08-29 | — | — | WO | disclosed |
| CN-113214220-B | Substituted 4-aminoisoindoline-1, 3-dione compounds and their use for the treatment of lymphomas | 细胞基因公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-109678840-B | Preparation method of pomalidomide | 河北菲尼斯生物技术有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-115572283-A | Pomalidomide feed additive and preparation method and application thereof | 河南湾流生物科技有限公司 | 2023-01-06 | — | — | CN | disclosed |
| CN-115557936-A | Preparation method and application of pomalidomide derivative capable of being used as feed additive | 河南湾流生物科技有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-108350062-B | Targeted protein degradation to attenuate adverse inflammatory responses associated with adoptive T cell therapy | 达纳-法伯癌症研究所股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-114907314-A | Chemical synthesis method of pomalidomide | 浙江工业大学 | 2022-08-16 | — | — | CN | disclosed |
| CN-114605381-A | Preparation method of pomalidomide | 南京海辰药业股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-114605381-A | Preparation method of pomalidomide | 南京海辰药业股份有限公司 | 2022-06-10 | — | — | CN | disclosed |